Generic medicines in India face scrutiny as the CDSCO grapples with substandard drugs, lack of human resources, state data blackouts, and MSME violations.
CGHS Crisis: Faulty generic drugs cause adverse reactions for beneficiaries, revealing flaws in the 2023 government circular and systemic healthcare failures.
/theprobe/media/media_files/2025/05/30/FXKqr9hKNPuxRuY9fHku.jpg)
/theprobe/media/media_files/2025/05/28/e91xpJub5jHZoPcdesXG.jpg)